Observation or Radical Treatment in Patients With Prostate Cancer
NCT00499174 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2023-08-23
Summary
RATIONALE: Sometimes prostate tumours may not need treatment until they progress. In this case, observation may be sufficient. Radical treatments, such as radical prostatectomy or radiation therapy, may be effective in treating prostate cancer when it is first diagnosed. It is not yet known whether active surveillance is more effective than radical treatment as an initial intervention in favorable prognosis prostate cancer.
PURPOSE: This randomized phase III trial is studying active surveillance to see how well it works compared with radical treatment as an initial intervention in patients with favorable prognosis prostate cancer.
Conditions
Interventions
- PROCEDURE
-
conventional surgery
Radical prostatectomy
- RADIATION
-
brachytherapy
high dose rate temporary seed implant; permanent seed implant.
- RADIATION
-
external beam radiation therapy
3D conformal radiation therapy; intensity modulated radiation therapy.
- PROCEDURE
-
Biopsies
Periodic repeat biopsies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Cancer and Leukemia Group B
collaborator NETWORK -
Eastern Cooperative Oncology Group
collaborator NETWORK -
SWOG Cancer Research Network
collaborator NETWORK -
Radiation Therapy Oncology Group
collaborator NETWORK -
Institute of Cancer Research, United Kingdom
collaborator OTHER -
NCIC Clinical Trials Group
lead NETWORK
Principal Investigators
-
Laurence H. Klotz, MD · Toronto Sunnybrook Regional Cancer Centre
-
Adam S. Kibel, MD · Washington University Siteman Cancer Center
-
Martin G. Sanda, MD · Beth Israel Deaconess Medical Center
-
Ian M. Thompson, MD · The University of Texas Health Science Center at San Antonio
-
Richard Choo, M.D · Mayo Clinic
-
Chris Parker, M.D · Royal Marsden Hospital, Sulton, UK
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-12-06
- Primary Completion
- 2011-12-31
- Completion
- 2013-01-10
Countries
- Canada
Study Locations
More Related Trials
-
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
NCT01492972 ·Status: RECRUITING ·Phase: PHASE3
-
Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study
NCT01376661 ·Status: TERMINATED
-
Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance
NCT05840484 ·Status: RECRUITING
-
Hypofractionated Whole Pelvic Radiotherapy of the Prostate
NCT02546427 ·Status: WITHDRAWN ·Phase: NA
-
Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate
NCT00691977 ·Status: WITHDRAWN ·Phase: PHASE1
-
High-Risk prostatE Cancer radiatiOn Versus surgERy
NCT05931419 ·Status: RECRUITING
-
Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer START
NCT03348722 ·Status: COMPLETED
-
Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy
NCT02003417 ·Status: COMPLETED
-
Feasibility Trial in Men With Hormone Sensitive Oligometastatic Prostate Cancer
NCT03301701 ·Status: WITHDRAWN ·Phase: NA
-
Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time
NCT01423474 ·Status: COMPLETED ·Phase: NA
-
Radiation and Androgen Ablation for Prostate Cancer
NCT01517451 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study Evaluating the Efficacy and the Tolerance of Pelvic-prostatic Hypo-fractionated Radiotherapy Followed by Boost in Patients With Prostate Adenocarcinoma Adverse Intermediate Risk or High Localized Risk
NCT03417336 ·Status: RECRUITING ·Phase: NA
-
Timing of Post-prostatectomy PSMA Imaging
NCT05008900 ·Status: COMPLETED ·Phase: PHASE2
-
Post-operative or Early Salvage XRT and ADT for High Risk PCa
NCT00949962 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk
NCT01717677 ·Status: TERMINATED ·Phase: NA
-
Stereotactic Focal Radiotherapy as an Alternative Treatment to Active Surveillance for Low and Intermediate Risk Prostate Cancer
NCT07152067 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT03541850 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prostate Testing for Cancer and Treatment
NCT02044172 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy
NCT02131649 ·Status: COMPLETED ·Phase: NA
-
Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate
NCT03034187 ·Status: RECRUITING
-
Prospective Clinical Study Comparing PROMS After Adaptive or Conventional Radiotherapy in Prostate Cancer
NCT07245745 ·Status: RECRUITING ·Phase: NA
-
Observational Study on Extreme Hypofractionation for Localized Prostate Cancer
NCT05344235 ·Status: RECRUITING
-
Radiotherapy vs Observation for CRPC
NCT01590498 ·Status: UNKNOWN
-
FACBC Outcomes for Post Prostatectomy
NCT01666808 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Active Surveillance Study
NCT05810467 ·Status: RECRUITING